Expert Interview
A Second Opinion: Discussing the potential implications of the Edwards Lifesciences EARLY-TAVR trial in asymptomatic patients with severe, calcific aortic stenosis.
Ticker(s): EW, MDT, ABTInstitution: Allina Health Minneapolis Heart Institute
- Director of Cardiac MRI, Structural CT and Cardiovascular Imaging Core Labs at Allina Health Minneapolis Heart Institute, Valve Science Center.
- Direct experience with Anteris DurAVR.
- Has participated in over 200 peer-reviewed original investigations, several book chapters, training workshops, national and international lectures, and is the Associate Editor for the European Heart Journal.
- Research interests include valvular heart disease and structural interventions, coronary artery disease, cardiomyopathies and multimodality imaging.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
